Exclusive interview for SPINOFF.COM with Liz Parrish, the CEO at BioViva, about their breakthrough regenerative gene therapies targeting the aging process
BioViva is a gene therapy innovation leader developing therapies to treat severe genetic disorders and cellular aging. They are working on several patents and are seeking strategic partnerships to help them make a positive step forward in their efforts to bring cures to an aging populations and to those who suffer from chronic and monogenic disease. BioViva’s mission is to create a world free of suffering from the conditions and diseases of biological aging by harnessing the power of gene and cell therapy. Their goal is to bring regenerative medicine to clinical application quickly, affordably and safely.